Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age
Clinical trial NCT04953884 · COMPLETED
Trial details
- NCT number
- NCT04953884
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2024-12-16
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.